0 225

Cited 0 times in

Differences in the Recurrence Rate of Immediate Adverse Drug Reactions According to the Components of Alternative Contrast Media: Analysis of Repetitive Computed Tomography Cases in a Single Tertiary Hospital

DC Field Value Language
dc.contributor.author박중원-
dc.contributor.author박혜정-
dc.contributor.author이재현-
dc.contributor.author박경희-
dc.contributor.author김성렬-
dc.date.accessioned2022-12-22T03:52:54Z-
dc.date.available2022-12-22T03:52:54Z-
dc.date.issued2022-09-
dc.identifier.issn0114-5916-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/191999-
dc.description.abstractIntroduction: The recurrence rates of immediate adverse drug reactions (ADRs) to the alternative radiocontrast media (RCM) are not well known. Previous studies suggest selection of alternative RCM considering carbamoyl side chains; however, its usefulness for preventing the recurrence of ADRs has not been clearly verified. Objective: The aim of this study was to verify the recurrence rate of immediate ADRs according to the alternative RCM. Method: This retrospective study analyzed 6420 contrast-enhanced computed tomography (CT) cases of 2009 patients registered in the ADR system from 861,664 CT cases in a single tertiary hospital between 2015 and 2020. Iohexol, iopromide, iobitridol, and iopamidol were used for CT. According to the carbamoyl side chains present, iohexol belongs to group 1, iopromide belongs to groups 1 and 2, iobitridol belongs to group 2, and iopamidol belongs to group 3. Results: Replacing iobitridol with iopamidol (odds ratio [OR] 2.595, 95% confidence interval [CI] 1.48-4.550) or iopromide (OR 3.354, 95% CI 1.420-7.926) as the subsequent RCM was associated with increased recurrence, while replacing iopamidol with iobitridol (OR 0.506, 95% CI 0.282-0.908) and iopromide with iohexol (OR 0.355, 95% CI 0.177-0.711) was associated with decreased recurrence. Other changes did not influence the recurrence of ADRs. Conclusions: The recurrence of immediate ADRs increased in certain RCM combinations of preceding and subsequent CT scans, and the RCMs did not show cross-reactivity. Therefore, the clinical benefit of the alternative RCM considering cross-reactivity is limited. This result suggests that the side chains of RCM do not have an important role in the recurrence of immediate ADRs.-
dc.description.statementOfResponsibilityrestriction-
dc.languageEnglish-
dc.publisherSpringer International-
dc.relation.isPartOfDRUG SAFETY-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.subject.MESHContrast Media* / adverse effects-
dc.subject.MESHDrug-Related Side Effects and Adverse Reactions*-
dc.subject.MESHHumans-
dc.subject.MESHIohexol / adverse effects-
dc.subject.MESHIopamidol / adverse effects-
dc.subject.MESHRetrospective Studies-
dc.subject.MESHTertiary Care Centers-
dc.subject.MESHTomography, X-Ray Computed / adverse effects-
dc.titleDifferences in the Recurrence Rate of Immediate Adverse Drug Reactions According to the Components of Alternative Contrast Media: Analysis of Repetitive Computed Tomography Cases in a Single Tertiary Hospital-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Internal Medicine (내과학교실)-
dc.contributor.googleauthorSung-Ryeol Kim-
dc.contributor.googleauthorNak-Hoon Son-
dc.contributor.googleauthorHye Jung Park-
dc.contributor.googleauthorKyung Hee Park-
dc.contributor.googleauthorJung-Won Park-
dc.contributor.googleauthorJae-Hyun Lee-
dc.identifier.doi10.1007/s40264-022-01213-z-
dc.contributor.localIdA01681-
dc.contributor.localIdA01769-
dc.contributor.localIdA03086-
dc.contributor.localIdA01427-
dc.contributor.localIdA00566-
dc.relation.journalcodeJ03981-
dc.identifier.eissn1179-1942-
dc.identifier.pmid35908149-
dc.identifier.urlhttps://link.springer.com/article/10.1007/s40264-022-01213-z-
dc.contributor.alternativeNamePark, Jung Won-
dc.contributor.affiliatedAuthor박중원-
dc.contributor.affiliatedAuthor박혜정-
dc.contributor.affiliatedAuthor이재현-
dc.contributor.affiliatedAuthor박경희-
dc.contributor.affiliatedAuthor김성렬-
dc.citation.volume45-
dc.citation.number9-
dc.citation.startPage995-
dc.citation.endPage1002-
dc.identifier.bibliographicCitationDRUG SAFETY, Vol.45(9) : 995-1002, 2022-09-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.